These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 19277041)
1. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. Ulasov IV; Sonabend AM; Nandi S; Khramtsov A; Han Y; Lesniak MS Br J Cancer; 2009 Apr; 100(7):1154-64. PubMed ID: 19277041 [TBL] [Abstract][Full Text] [Related]
2. Cancer cell death by design: apoptosis, autophagy and glioma virotherapy. Tyler MA; Ulasov IV; Lesniak MS Autophagy; 2009 Aug; 5(6):856-7. PubMed ID: 19430207 [TBL] [Abstract][Full Text] [Related]
3. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. Cheng Y; Sk UH; Zhang Y; Ren X; Zhang L; Huber-Keener KJ; Sun YW; Liao J; Amin S; Sharma AK; Yang JM PLoS One; 2012; 7(4):e35104. PubMed ID: 22496897 [TBL] [Abstract][Full Text] [Related]
4. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma. Tobias AL; Thaci B; Auffinger B; Rincón E; Balyasnikova IV; Kim CK; Han Y; Zhang L; Aboody KS; Ahmed AU; Lesniak MS Stem Cells Transl Med; 2013 Sep; 2(9):655-66. PubMed ID: 23926209 [TBL] [Abstract][Full Text] [Related]
5. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy. Ulasov IV; Tyler MA; Zhu ZB; Han Y; He TC; Lesniak MS Int J Oncol; 2009 Mar; 34(3):729-42. PubMed ID: 19212678 [TBL] [Abstract][Full Text] [Related]
7. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. Kaliberova LN; Krendelchtchikova V; Harmon DK; Stockard CR; Petersen AS; Markert JM; Gillespie GY; Grizzle WE; Buchsbaum DJ; Kaliberov SA Cancer Gene Ther; 2009 Oct; 16(10):794-805. PubMed ID: 19363468 [TBL] [Abstract][Full Text] [Related]
8. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Gomez-Gutierrez JG; Nitz J; Sharma R; Wechman SL; Riedinger E; Martinez-Jaramillo E; Sam Zhou H; McMasters KM Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
10. Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma. Magaña-Maldonado R; Manoutcharian K; Hernández-Pedro NY; Rangel-López E; Pérez-De la Cruz V; Rodríguez-Balderas C; Sotelo J; Pineda B J Cancer Res Clin Oncol; 2014 Feb; 140(2):291-301. PubMed ID: 24337403 [TBL] [Abstract][Full Text] [Related]
11. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993 [TBL] [Abstract][Full Text] [Related]
12. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
13. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5. Fiveash JB; Gillespie GY; Oliver PG; Zhou T; Belenky ML; Buchsbaum DJ Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):507-16. PubMed ID: 18474311 [TBL] [Abstract][Full Text] [Related]
15. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth. Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126 [TBL] [Abstract][Full Text] [Related]
17. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Kanzawa T; Germano IM; Komata T; Ito H; Kondo Y; Kondo S Cell Death Differ; 2004 Apr; 11(4):448-57. PubMed ID: 14713959 [TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo. Jiang G; Sun C; Li RH; Wei ZP; Zheng JN; Liu YQ J Cancer Res Clin Oncol; 2015 Jan; 141(1):75-85. PubMed ID: 25103017 [TBL] [Abstract][Full Text] [Related]
19. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. Holzmüller R; Mantwill K; Haczek C; Rognoni E; Anton M; Kasajima A; Weichert W; Treue D; Lage H; Schuster T; Schlegel J; Gänsbacher B; Holm PS Int J Cancer; 2011 Sep; 129(5):1265-76. PubMed ID: 21710499 [TBL] [Abstract][Full Text] [Related]
20. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction. Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]